JP2023089191A5 - - Google Patents

Download PDF

Info

Publication number
JP2023089191A5
JP2023089191A5 JP2023067121A JP2023067121A JP2023089191A5 JP 2023089191 A5 JP2023089191 A5 JP 2023089191A5 JP 2023067121 A JP2023067121 A JP 2023067121A JP 2023067121 A JP2023067121 A JP 2023067121A JP 2023089191 A5 JP2023089191 A5 JP 2023089191A5
Authority
JP
Japan
Prior art keywords
sequence
seq
antibody
fragment
light chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023067121A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023089191A (ja
Filing date
Publication date
Priority claimed from PCT/NL2019/050018 external-priority patent/WO2019139481A1/en
Application filed filed Critical
Publication of JP2023089191A publication Critical patent/JP2023089191A/ja
Publication of JP2023089191A5 publication Critical patent/JP2023089191A5/ja
Pending legal-status Critical Current

Links

JP2023067121A 2018-01-15 2023-04-17 H因子増強抗体及びその使用 Pending JP2023089191A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18151726.9 2018-01-15
EP18151726 2018-01-15
PCT/NL2019/050018 WO2019139481A1 (en) 2018-01-15 2019-01-15 Factor h potentiating antibodies and uses thereof
JP2020538984A JP7471224B2 (ja) 2018-01-15 2019-01-15 H因子増強抗体及びその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020538984A Division JP7471224B2 (ja) 2018-01-15 2019-01-15 H因子増強抗体及びその使用

Publications (2)

Publication Number Publication Date
JP2023089191A JP2023089191A (ja) 2023-06-27
JP2023089191A5 true JP2023089191A5 (cg-RX-API-DMAC7.html) 2023-12-08

Family

ID=60972152

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020538984A Active JP7471224B2 (ja) 2018-01-15 2019-01-15 H因子増強抗体及びその使用
JP2023067121A Pending JP2023089191A (ja) 2018-01-15 2023-04-17 H因子増強抗体及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020538984A Active JP7471224B2 (ja) 2018-01-15 2019-01-15 H因子増強抗体及びその使用

Country Status (11)

Country Link
US (2) US11377487B2 (cg-RX-API-DMAC7.html)
EP (1) EP3740502A1 (cg-RX-API-DMAC7.html)
JP (2) JP7471224B2 (cg-RX-API-DMAC7.html)
KR (2) KR20250171487A (cg-RX-API-DMAC7.html)
CN (1) CN111868083B (cg-RX-API-DMAC7.html)
AU (1) AU2019206207B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020014399A2 (cg-RX-API-DMAC7.html)
CA (1) CA3088507A1 (cg-RX-API-DMAC7.html)
IL (1) IL276008A (cg-RX-API-DMAC7.html)
MX (1) MX2020007555A (cg-RX-API-DMAC7.html)
WO (1) WO2019139481A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019206207B2 (en) * 2018-01-15 2025-04-10 Stichting Sanquin Bloedvoorziening Factor H potentiating antibodies and uses thereof
JP7631296B2 (ja) * 2019-07-17 2025-02-18 ジェミニ・セラピューティクス・サブ・インコーポレイテッド H因子増強性抗体及びその使用
KR20230113578A (ko) * 2020-11-27 2023-07-31 선샤인 레이크 파르마 컴퍼니 리미티드 Cldn18.2 항체 및 그의 용도
KR20240040098A (ko) * 2021-07-30 2024-03-27 알.피.쉐러 테크놀러지즈 엘엘씨 넥틴-4에 특이적인 항체 및 항체 접합체 및 이의 사용방법
CN116355860A (zh) * 2021-12-28 2023-06-30 四川远大蜀阳药业有限责任公司 分泌抗h因子抗体的杂交瘤细胞株、抗h因子抗体及其应用
CN116655792B (zh) * 2022-03-21 2024-01-02 南京蓬勃生物科技有限公司 靶向Siglec-15的单克隆抗体及其应用
NL2032398B1 (en) * 2022-07-06 2024-01-23 Academisch Ziekenhuis Leiden Bispecific antibody and uses thereof
CN118878671B (zh) * 2024-07-04 2025-09-30 南京农业大学 抗兽疫链球菌SzM蛋白的猪源化单克隆抗体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580714B2 (en) 2009-10-14 2013-11-12 Janssen Biotech, Inc. Methods of affinity maturing antibodies
CA2780221A1 (en) 2009-11-04 2011-05-12 Fabrus Llc Methods for affinity maturation-based antibody optimization
AU2015304079B2 (en) 2014-08-20 2021-05-13 Stichting Sanquin Bloedvoorziening Factor H potentiating antibodies and uses thereof
KR102485788B1 (ko) 2014-08-27 2023-01-09 메모리얼 슬로안 케터링 캔서 센터 항체, 조성물 및 용도
AU2019206207B2 (en) * 2018-01-15 2025-04-10 Stichting Sanquin Bloedvoorziening Factor H potentiating antibodies and uses thereof
JP7631296B2 (ja) * 2019-07-17 2025-02-18 ジェミニ・セラピューティクス・サブ・インコーポレイテッド H因子増強性抗体及びその使用

Similar Documents

Publication Publication Date Title
JP2021510523A5 (cg-RX-API-DMAC7.html)
JP2024150751A5 (cg-RX-API-DMAC7.html)
JP2022537780A5 (cg-RX-API-DMAC7.html)
JP2024020298A5 (cg-RX-API-DMAC7.html)
JP2021063090A5 (cg-RX-API-DMAC7.html)
RU2019140602A (ru) АНТИ-GARP-TGF-β-АНТИТЕЛА
JP2020510646A5 (cg-RX-API-DMAC7.html)
JP2021519295A5 (cg-RX-API-DMAC7.html)
JP2019505527A5 (cg-RX-API-DMAC7.html)
JP6410712B2 (ja) Il−6結合分子
JP2018500014A5 (cg-RX-API-DMAC7.html)
JP2018506277A5 (cg-RX-API-DMAC7.html)
JP2022524588A5 (cg-RX-API-DMAC7.html)
JP2022533538A5 (cg-RX-API-DMAC7.html)
JP2018510617A5 (cg-RX-API-DMAC7.html)
JP2019527194A5 (cg-RX-API-DMAC7.html)
JP2020507577A5 (cg-RX-API-DMAC7.html)
JP2019513726A5 (cg-RX-API-DMAC7.html)
JP2024541680A5 (cg-RX-API-DMAC7.html)
JP2022512647A5 (cg-RX-API-DMAC7.html)
JP2022512713A5 (cg-RX-API-DMAC7.html)
JP2024024114A5 (cg-RX-API-DMAC7.html)
JP2022536469A5 (cg-RX-API-DMAC7.html)
JP2018529661A5 (cg-RX-API-DMAC7.html)
JP2024518844A5 (cg-RX-API-DMAC7.html)